Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

SHE:002932 Revenue

Wuhan Easy Diagnosis Biomedicine had revenue of 70.67M CNY in the quarter ending March 31, 2026, with 1.01% growth. This brings the company's revenue in the last twelve months to 265.79M, down -25.98% year-over-year. In the year 2025, Wuhan Easy Diagnosis Biomedicine had annual revenue of 265.08M, down -24.28%.

• Revenue (ttm): 265.79M
• Revenue Growth: -25.98%
• P/S Ratio: 12.66
• Revenue / Employee: 443.71K
• Employees: 599
• Market Cap: 3.36B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	265.08M	-84.98M	-24.28%
Dec 31, 2024	350.06M	-399.47M	-53.30%
Dec 31, 2023	749.54M	-9.78B	-92.88%
Jan 1, 2023	10.53B	7.70B	272.12%
Jan 1, 2022	2.83B	1.87B	195.05%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error